MENU
RLMD
AS OF
Jan 3 closing price
Price
$0.47
Change
+$0.02 (+4.44%)
Capitalization
14.18M
79 days until earnings call
RLMD
Stock ticker: NASDAQ
AS OF
Jan 3 closing price
Price
$0.47
Change
+$0.02 (+4.44%)
Capitalization
14.18M
RLMD Relmada Therapeutics Chart, History Price & Graph
a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
RLMD and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To RLMD | 1D Price Change % | ||
|---|---|---|---|---|
| RLMD | 100% | +4.44% | ||
| SYRE - RLMD | 36% Loosely correlated | +2.10% | ||
| ENTO - RLMD | 36% Loosely correlated | -4.32% | ||
| ALVR - RLMD | 35% Loosely correlated | +0.91% | ||
| SCPX - RLMD | 34% Loosely correlated | +59.48% | ||
| PRTC - RLMD | 31% Poorly correlated | -3.51% | ||
More | ||||